CD19-CAR-T2 Cells for CD19 Positive B Cell Malignancies
Clinical trial NCT04605666 · COMPLETED
Trial details
- NCT number
- NCT04605666
- Sponsor
- Nanfang Hospital, Southern Medical University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-01
- Primary completion
- 2023-06-30
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.